Fig. 3From: Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimenVariation in SUVmax between baseline and 6 and 12-week PET/CT; Patients undergoing consolidation CRT had significant increased variation between baseline and 6 or 12-week PET/CT (<0.001)Back to article page